BRVE
Braveheart Bio, Inc.
There isn't enough reported data to score BRVE yet.
BRVE Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate BRVE's fundamentals.
BRVE PE Valuation
BRVE has no meaningful PE right now: it lost money over the past year.
BRVE Forward outlook
There aren't enough analyst estimates for BRVE to show an outlook.
BRVE Earnings Per Share
BRVE Quarterly Revenue
BRVE Free Cash Flow
BRVE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +604% | +44.7M shares |
BRVE Net Leverage
BRVE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BRVE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 19.3 | Oversold |
As of the close on Nov 12, 2026: $20.50.
BRVE PE vs Healthcare Sector
BRVE has no meaningful PE right now: it lost money over the past year.
BRVE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $20.3 | 0.8% above |
BRVE is in an uptrend: it's above all one of its weekly moving averages, and 0.8% above its 8-week average.
BRVE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2026 YTD | $30.0 | $20.5 | -32% |
It's down 32% so far in 2026.